Benefit assessment of salt reduction in patients with hypertension: Systematic overview

Journal of Hypertension

Volumn 29, Issue 5, 2011, Pages 821-828

  Matyas, Eva ^a   Jeitler, Klaus ^a,b   Horvath, Karl ^a   Semlitsch, Thomas ^a   Hemkens, Lars G ^c   Pignitter, Nicole ^a   Siebenhofer, Andrea ^d  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

diet; dietary; hypertension; sodium; sodium restricted

Indexed keywords

ADVERSE OUTCOME; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MEDICAL LITERATURE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SALT INTAKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 79954621266     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283442840     Document Type: Review

References (59)

1. World Health Organization (WHO). The World Health Report 2002: reducing risks, promoting healthy life; 2002. http://www.who.int/entity/ whr/2002/en/whr02-en.pdf. [Accessed 16 February 2010].
2. Staessen JA, Li Y, Thijs L, Wang JG. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Hypertens Res 2005; 28:385-407. (Pubitemid 41014801)
3. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535. (Pubitemid 37410190)
4. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II: analysis of observational data within populations. BMJ 1991; 302:815-818.
5. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III: analysis of data from trials of salt reduction. BMJ 1991; 302:819-824.
6. Wannamethee SG, Shaper AG. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 1996; 27:1033-1039. (Pubitemid 26177602)
7. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162:1867-1872.
8. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006; 24:215-233.
9. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004:CD004937.
10. Jü rgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev 2004:CD004022.
11. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339:b4567.
12. European Society of Hypertension, European Society of Cardiology. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
13. National Institute for Health and Clinical Excellence (NICE). Essential hypertension: managing adult patients in primary care. 2004. http:// www.nice.org.uk/nicemedia/pdf/CG18background.pdf. [Accessed 16 February 2010].
14. World Health Organization (WHO). Clinical guidelines for the management of hypertension; 2005. http://www.emro.who.int/dsaf/ dsa234.pdf. [Accessed 16 February 2010].
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
16. Canadian Hypertension Education Program (CHEP). Recommendations for the Management of Hypertension. http://hypertension.ca/downloads/ chep/ids/docs/PDF/Complete-Recommendations-2009.pdf. [Accessed .16. February 2010].
17. Institute for Quality and Efficiency in Healthcare. General Methods: Version 3.0. http://www.iqwig.de/download/IQWiG-General-methods-V-3-0.pdf. [Accessed 16 February 2010].
18. Becker LA, Oxman AD. Chapter 22. Overviews of reviews; 2008. http:// www.cochrane-handbook.org/. [Accessed 16 February 2010].
19. Horvath K, Jeitler K, Siering U, Stich AK, Skipka G, Gratzer TW, Siebenhofer A. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Arch Intern Med 2008; 168:571-580. (Pubitemid 351468391)
20. Institut fü r Qualitä t und Wirtschaftlichkeit im Gesundheitswesen. Nutzenbewertung nichtmedikamentö ser Behandlungsstrategien bei Patienten mit Bluthochdruck: Gewichtsreduktion; Abschlussbericht. Version 1.0; A05-21A. https://www.iqwig.de/download/A05- 21A-Abschlussbericht-Gewichtsreduktion-bei-Bluthochdruck-neu.pdf. [Accessed 9 October 2009].
21. Siebenhofer A, Horvath K, Jeitler K, Berghold A, Stich AK, Matyas E, et al. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2009:CD007654.
22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700.
23. Institut fü r Qualitä t und Wirtschaftlichkeit im Gesundheitswesen. Nutzenbewertung nichtmedikamentö ser Behandlungsstrategien bei Patienten mit essenzieller Hypertonie: Kochsalzreduktion; Rapid Report. Version 1.0; A05-21B. http://www.iqwig.de/ download/ A05-21B-Rapid-Report-Nichtmedikamentoese-Behandlungsstrategien- bei-Hypertonie-Kochsalzreduktion.pdf. [Accessed 16 February 2010].
24. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol 1991; 44:1271-1278.
25. Oxman AD, Guyatt GH, Singer J, Goldsmith CH, Hutchison BG, Milner RA, Streiner DL. Agreement among reviewers of review articles. J Clin Epidemiol 1991; 44:91-98.
26. He FJ, MacGregorGA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health [see comment]. J Hum Hypertens 2002; 16:761-770. (Pubitemid 36007929)
27. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003; 42:1093-1099. (Pubitemid 37549061)
28. Hooper L, Bartlett C, Davey SG, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease [update of Cochrane Database Syst Rev 2003:CD003656; PMID: 12917977]. Cochrane Database Syst Rev 2004:CD003656.
29. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults [see comment]. BMJ 2002; 325:628.
30. Morgan T, Adam W, Gillies A, Wilson M, Morgan G, Carney S. Hypertension treated by salt restriction. Lancet 1978; 1:227-230. (Pubitemid 8268154)
31. Alli C, Avanzini F, Bettelli G, Bonati M, Colombo F, Corso R, et al. Feasibility of a long-term low-sodium diet in mild hypertension. J Hum Hypertens 1992; 6:281-286.
32. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of Nonpharmacologic Interventions in the Elderly (TONE). TONE Collaborative Research Group. JAMA 1998; 279:839-846. (Pubitemid 28185548)
33. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001; 161:685-693. (Pubitemid 32200220)
34. Thaler BI, Paulin JM, Phelan EL, Simpson FO. A pilot study to test the feasibility of salt restriction in a community. N Z Med J 1982; 95:839-842. (Pubitemid 13132585)
35. Morgan TO, Adams WR, Hodgson M, Gibberd RW. Failure of therapy to improve prognosis in elderly males with hypertension. Med J Aust 1980; 2:27-31. (Pubitemid 11198173)
36. Morgan T, Anderson A. Sodium restriction can delay the return of hypertension in patients previously well controlled on drug therapy. Can J Physiol Pharmacol 1987; 65:1752-1755.
37. Arroll B, Beaglehole R. Salt restriction and physical activity in treated hypertensives. N Z Med J 1995; 108:266-268.
38. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, MacGregor GA. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54:482-488.
39. Meland E, Aamland A. Salt restriction among hypertensive patients: modest blood pressure effect and no adverse effects. Scand J Prim Healthcare 2009; 27:97-103.
40. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
41. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
42. Khaw KT, Bingham S, Welch A, Luben R, O'Brien E, Wareham N, Day N. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr 2004; 80:1397-1403.
43. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297:319-328.
44. Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, Marmot M. Intersalt revisited: further analyses of 24 h sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312:1249-1253. (Pubitemid 26147660)
45. Klaus D, Hoyer J, Middeke M. Salt restriction for the prevention of cardiovascular disease. Dtsch Arztebl Int 2010; 107:457-462.
46. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10. (Pubitemid 32064838)
47. Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin PH, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010; 170:126-135.
48. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334:885-888. (Pubitemid 46724330)
49. World Health Organization (WHO). Reducing salt intake in populations; 2007. http://www.who.int/dietphysicalactivity/reducingsaltintake-EN.pdf. [Accessed 16 February 2010].
50. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-2693. (Pubitemid 39665322)
51. Godlee F. The food industry fights for salt. BMJ 1996; 312:1239-1240. (Pubitemid 26147655)
52. Consensus Action on Salt and Health (CASH). http:// www.actiononsalt.org. uk/. [Accessed 10 November 2010].
53. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590-599.
54. Klaus S, Middeke L, Hoyer H. An appeal to start a Task Force 'Lower salt intake for everybody' [in German]. Dtsch Med Wochenschr 2008; 133:1317-1319.
55. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
56. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
57. Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health study. Arch Intern Med 2002; 162:2325-2332. (Pubitemid 35332515)
58. Fahey T, Schroeder K, Ebrahim S. Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract 2005; 55:875-882. (Pubitemid 41684003)
59. Trocha AK, Schmidtke C, Didjurgeit U, Muhlhauser I, Bender R, Berger M, Sawicki PT. Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens 1999; 17:1497-1503. (Pubitemid 29509497)